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Tuberculosis (TB) is a worldwide public health 
issue that, as a result of active intervention, is 
lowering in incidence (Dye et al., 2013). How-
ever, new tools are required to have any realistic 
chance of eliminating this disease. The required 
tools include improved diagnosis of active dis-
ease, improved drug therapy, and new vaccine 
strategies (Dye et al., 2013). To develop a pro-
tective vaccine, it is critical that we identify 
the constituents of protective immunity to TB. 
Data from AIDS patients clearly indicate a role 
for CD4+ T cells (Havlir and Barnes, 1999; 
Geldmacher et al., 2012), and the acute suscep-
tibility seen in individuals lacking genes in the 
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CD4+ T cells mediate protection against Mycobacterium tuberculosis (Mtb); however, the 
phenotype of protective T cells is undefined, thereby confounding vaccination efforts. IL-27 
is highly expressed during human tuberculosis (TB), and absence of IL-27R (Il27ra) specifi-
cally on T cells results in increased protection. IL-27R deficiency during chronic Mtb infec-
tion does not impact antigen-specific CD4+ T cell number but maintains programmed 
death-1 (PD-1), CD69, and CD127 expression while reducing T-bet and killer cell lectin-
like receptor G1 (KLRG1) expression. Furthermore, T-bet haploinsufficiency results in 
failure to generate KLRG1+, antigen-specific CD4+ T cells, and in improved protection.  
T cells in Il27ra/ mice accumulate preferentially in the lung parenchyma within close 
proximity to Mtb, and antigen-specific CD4+ T cells lacking IL-27R are intrinsically more fit 
than intact T cells and maintain IL-2 production. Improved fitness of IL-27R–deficient  
T cells is not associated with increased proliferation but with decreased expression of cell 
death–associated markers. Therefore, during Mtb infection, IL-27R acts intrinsically on  
T cells to limit protection and reduce fitness, whereas the IL-27R–deficient environment 
alters the phenotype and location of T cells. The significant expression of IL-27 in TB and 
the negative influence of IL-27R on T cell function demonstrate the pathway by which this 
cytokine/receptor pair is detrimental in TB.
© 2015 Torrado et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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2014). Indeed, PD-1+ CD4+ T cells make low levels of IFN 
and proliferate in contrast to KLRG1+ CD4+ T cells, which 
make high levels of IFN but do not proliferate (Reiley et al., 
2010). Moreover, in adoptive transfer experiments, PD-1+ 
CD4+ T cells differentiate into KLRG1+, whereas KLRG1+ 
CD4+ T cells maintain their phenotype and undergo rapid 
contraction (Reiley et al., 2010). These data support a model 
wherein the PD-1+ population represents a self-renewing 
pool within the effector population with the potential to give 
rise to short-lived, KLRG1+ CD4+ T cells (Reiley et al., 2010), 
particularly in response to a dominant epitope (Woodworth 
et al., 2014). Furthermore, although CD4+ KLRG1+ cells are 
strong effector cytokine producers, they have recently been 
shown to be CXCR3 and to have limited ability to migrate 
to the lung parenchyma and mediate control of Mtb (Sakai 
et al., 2014). This limited capacity to enter the lung paren-
chyma and engage with infected macrophage is a critical failing 
as T cells, which cuff around blood vessels rather than penetrat-
ing the lesion, fail to achieve optimal bacterial control (Khader 
et al., 2009, 2011), and direct interaction of CD4+ T cells with 
Mtb-infected phagocytes is critical for the protective function 
of CD4+ T cells (Srivastava and Ernst, 2013). Furthermore, 
development of KLRG1+ antigen-specific T cells after vacci-
nation is not associated with prolonged protection, whereas 
KLRG1 IL-2–producing cells are (Lindenstrøm et al., 2009). 
Therefore, it is clear that not all effector CD4+ T cells are equally 
protective, which makes it critical that we define the factors 
leading to the differentiation of protective rather than ineffective 
CD4+ T cells. This will lead to the rational design of vaccines 
capable of promoting T cells that can enter the lung lesions, sur-
vive within them, and thereby mediate long-term protection.
Here we found that IL-27 is expressed during active TB 
in humans and that the loss of IL-27 receptor (IL-27R) solely 
on T cells results in improved protection in mice. We found 
that the absence of IL-27R expression during chronic Mtb 
results in antigen-specific T cells, which maintain PD-1, 
CD69, and CD127 while reducing T-bet and KLRG1 ex-
pression and which accumulate preferentially in the paren-
chyma, within close proximity to Mtb antigen. Antigen-specific 
T cells lacking IL-27R are intrinsically more fit than intact 
T cells, they maintain IL-2 production, and they exhibit re-
duced cell death markers. Our data support the hypothesis 
that IL-27R activity acts both intrinsically by directly impact-
ing the T cells and extrinsically by altering the environment 
and that it is the combination of these effects that results in 
antigen-specific T cells with reduced protective efficacy. These 
data have important implications for the development of novel 
vaccination strategies for TB.
RESULTS
Absence of IL-27R on T cells results  
in reduced Mtb burden in the lung
In previous studies, the absence of IL-27R in the Mtb- 
infected mouse model resulted in reduced bacterial burden 
in the lungs of gene-deficient mice (Pearl et al., 2004; Hölscher 
et al., 2005). The components of IL-27 have also been seen 
IFN macrophage activation pathway (Casanova and Abel, 
2002; Filipe-Santos et al., 2006) supports the importance of 
CD4+ T cells producing IFN as an appropriate target for 
vaccine-induced protection. However, in humans the IFN 
response is not a reliable correlate of protection (Elias et al., 
2005), and a recent vaccine targeting the induction of IFN-
producing T cells did not demonstrate improved efficacy over 
BCG vaccination alone (Tameris et al., 2013). Although new 
concepts should be developed, it is not yet appropriate to dis-
miss cytokine-producing CD4+ T cells as targets for effective 
vaccination, particularly as we do not know what the essential 
components of an effective CD4+ T cell response to TB are. 
Critical features of the protective CD4+ T cell response de-
pend on kinetics of recruitment to the lung as well as survival 
and location of the cells within the lung when they arrive 
(Cooper, 2009; Sakai et al., 2014). We and others discovered 
that mice infected with Mycobacterium tuberculosis (Mtb), which 
lacked the  subunit of the IL-27 receptor (IL-27Ra, Il27ra/ 
mice), are able to maintain lower bacterial burdens in the lung 
compared with control mice (Pearl et al., 2004; Hölscher et al., 
2005). Conversely, these mice exhibited increased suscepti-
bility to disease as a result of an enhanced inflammatory re-
sponse (Hölscher et al., 2005). These data suggest that IL-27 
could play a regulatory role that dually limits protective func-
tion, perhaps to limit immunopathology.
IL-27 is a heterodimeric cytokine formed by the associa-
tion of the subunits p28 (Il27) and Epstein-Barr virus–induced 
gene 3 (EBI3 [Ebi3]; Pflanz et al., 2002). Although myeloid cells 
are the main source of the cytokine, its receptor, composed 
of WSX1/TCCR (encoded by Il27ra) and glycoprotein 130 
(gp130; encoded by Il6st), is expressed in multiple cells (Pflanz 
et al., 2004). IL-27 induces expression of the Th1 transcription 
factors T-bet and STAT1, resulting in up-regulation of the 
IL-12R2 chain, thus enhancing the responsiveness of naive 
T cells to IL-12 (Hibbert et al., 2003; Takeda et al., 2003). How-
ever, mice deficient in Il27ra or Ebi3 do not display major de-
fects in IFN-mediated responses (Yoshida et al., 2001; Artis 
et al., 2004), suggesting that where IL-12 is not limiting, IL-27 
is most likely redundant for this function. This appears to be the 
case during Mtb infection in Il27ra/ mice, wherein the ki-
netics of IFN-producing T cell accumulation in the lungs are 
not impaired (Pearl et al., 2004; Hölscher et al., 2005), although 
antigen-specific T cells from the lungs of Il27ra/ mice pro-
duce lower amounts of IFN on a per-cell basis (Pearl et al., 
2004). Because IFN and IFN-producing T cells are thought 
to be required for efficient macrophage activation and con-
tainment of Mtb growth, the effects of IL-27R during TB 
seem counterintuitive and need to be further examined.
IL-27 acts to define the T cell phenotype in many infec-
tion models (Hunter and Kastelein, 2012), and distinct phe-
notypes of CD4+ T cells develop during Mtb infection in 
mice (Reiley et al., 2010). CD4+ T cells in the lungs of in-
fected mice express programmed death-1 (PD-1) and killer 
cell lectin-like receptor G1 (KLRG1), which are not associ-
ated with functional exhaustion, but rather with distinct 
functional properties (Reiley et al., 2010; Sakai et al., 
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The IL-27R–deficient environment impacts CD4+ T cell 
phenotype during Mtb infection
To further define the role of IL-27 in TB, we determined the 
impact of the IL-27R–deficient environment on the pheno-
type of antigen-specific T cells in the TB lesion. Using the I-Ab 
ESAT-64–17 multimer (specific for the I-Ab restricted epitope 
of the early secreted antigenic target-6 [ESAT-6]), we found 
that ESAT-6–specific CD4+ T cells expressed high levels of 
in TB granuloma (Larousserie et al., 2004) and in TB pleural 
effusion (Yang et al., 2012). Therefore, we wanted to de-
termine whether IL-27 expression was associated with ac-
tive disease in humans. To do this, we reanalyzed published 
data wherein whole blood RNA expression profiles were 
assessed for a large number of adults with TB in a case-control 
study in HIV+ and HIV populations from South Africa 
and Malawi (Kaforou et al., 2013). In the South African co-
hort, IL-27 expression was not significantly associated with 
HIV status (P = 0.2), but was significantly higher in TB 
cases compared with latently infected individuals (latent TB 
[LTB]; P = 3 × 1024) and compared with patients with 
other diseases (OD; P = 2 × 109; Fig. 1 A). In the Malawi 
cohort, IL-27 expression was generally enhanced in HIV+ 
compared with HIV participants (P = 4 × 109), but was 
nevertheless higher in TB cases compared with LTB (P = 1017; 
Fig. 1 A), and HIV had no significant effect on the differ-
ence in IL-27 levels between TB cases and LTB (P = 0.50). 
Furthermore, we examined IL-27 expression in TB patients 
coinfected with HIV who were experiencing immune re-
constitution inflammatory syndrome (IRIS) as a result of 
antiretroviral therapy (ART; Lai et al., 2013). In a case-
control study, we found that PBMCs from IRIS cases tran-
scribe more IL-27p28 in response to Mtb than do PBMCs 
from controls (Fig. 1 B, left). We also used a prospective obser-
vational study to compare the IL-27p28 response at baseline 
between those TB/HIV individuals who developed IRIS with 
those who did not. We found that those who developed IRIS 
had a higher level of IL-27p28 in their plasma than did those 
who did not develop IRIS (Fig. 1 B, right). These data sup-
port the hypothesis that IL-27 is strongly up-regulated during 
active TB and that it may play a role in development of IRIS. 
These observations support further detailed analysis of the 
role of IL-27 in TB.
Many studies have implicated IL-27 as a modulator of 
T cell differentiation; however, the receptor for this cytokine 
is expressed widely throughout the immune system (Pflanz 
et al., 2004). Therefore, it was necessary to determine whether 
expression of IL-27R on T cells recapitulates the phenotype 
in the total gene-deleted mouse. To do this, we generated 
mice wherein only and all T cells are IL-27R deficient using 
BM chimeras with TCR/ mice as hosts reconstituted 
with either 75% TCR/ and 25% Il27ra/ BM (all 
T cells IL-27R deficient) or 75% TCR/ and 25% C57BL/6 
BM (all T cells are IL-27R sufficient; Fig. 1 C). These mice 
were efficiently reconstituted and repopulated the T cell com-
partment to an equivalent degree (not depicted). Upon suc-
cessful reconstitution, the mice were infected via the aerosol 
route with Mtb and the bacterial burden in the lung was deter-
mined. We found that the number of bacteria in the lungs of 
the chimeras lacking IL-27R on their T cells was significantly 
reduced relative to the intact chimeras (Fig. 1 C) and that the 
bacterial burdens were similar to those we observed for intact 
and Il27ra/ deficient mice (Pearl et al., 2004). These data 
demonstrate that IL-27R expression on T cells results in a 
higher bacterial burden in the lungs of Mtb-infected mice.
Figure 1. IL-27 is associated with active TB in humans, and resis-
tance of Il27ra/ mice to Mtb locates to the T cell compartment. 
(A) To determine whether expression of IL-27 production is associated 
with active TB, microarray data were analyzed for the log2 expression 
(log2[1 + E  min(E)], where E represents the initial normalized data) of 
IL27A (p28 subunit). Plotted are log2 expression values after combining 
HIV+ and HIV cohorts and subtracting the global mean (South Africa)  
or residuals after modeling IL-27 expression as a function of HIV  
(Malawi). (B) To link excess IL-27 to IRIS, we (left) compared the  
Mtb-induced mRNA for IL27A between PBMCs from patients suffering 
from TB-IRIS (IRIS; n = 22) and from case controls (Non-IRIS; n = 19).  
The median and interquartile range are shown. (right) The level of  
IL-27p28 in the plasma of ART-naive HIV/TB patients who either did  
(IRIS; n = 33) or did not (Non-IRIS; n = 30) develop IRIS during ART.  
*, P < 0.05 by Mann-Whitney test. (C) TCR/ mice were lethally  
irradiated and transplanted with a mixture of 75% TCR/ plus 25% 
B6 (/ B6) or Il27ra/ (/ Il27ra/) BM. Reconstituted mice 
were aerosol infected with Mtb, and bacterial burdens were determined 
after infection. Data are representative of two independent experiments, 
each with four mice per group. Error bars represent the mean ± SD.  
*, P < 0.05; **, P < 0.005.
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T-bet+ CD4+ T cells, which differ in expression of CD69, dif-
ferentially accumulate in mycobacterial lesions (Pearl et al., 
2012), and we found that the frequency of antigen-specific, 
T-bet+ CD69+ T cells increased in the Il27ra/ mice during 
chronic infection relative to the B6 mice (Fig. 2, C and D). 
CD44 (Fig. 2 A) and that there was an equal number of ESAT-6– 
specific CD4+ T cells in the lungs of both Mtb-infected B6 
and Il27ra/ mice (Fig. 2 B). Antigen-specific CD8+ T cells, 
which bound the H-2Kb TB10.44-11 tetramer (Woodworth 
et al., 2008), also did not differ in number (Fig. 2 B). CD44+ 
Figure 2. IL-27R impacts the phenotype of lung CD4+ T cells during TB. (A and B) Representative FACS analysis of lung CD4+ T cells for CD44 and 
ESAT-6 tetramer at day 60 after infection (A) and number of I-Ab ESAT-64–17–specific CD4+ (left) and H-2Kb TB10.44–11–specific CD8+ (right) T cells in the 
lungs of B6 and Il27ra/ mice throughout Mtb infection (B). CD4 data are representative of three total independent experiments each with four to five 
mice per group. CD8 data are representative of two independent experiments with four mice per group. (C and D) Representative FACS analysis of CD69 
expression by I-Ab ESAT-64–17–specific CD4+ and H-2Kb TB10.44–11–specific CD8+ T cells from B6 or Il27ra/ mice at day 110 after infection (C) and the 
number of CD69-expressing antigen-specific CD4 and CD8 T cells in the lungs of B6 or Il27ra/ after infection (D). CD4 data are representative of three 
independent experiments, each with four to five mice per group. CD8 data points represent two independent experiments with three to four mice per 
group. (E) Representative FACS analysis and geometric MFI of CD127 expression in I-Ab ESAT-64–17–specific CD4+ T cells in the lungs of B6 or IL-27R/ 
mice at day 160 after infection. Data are representative of two independent experiments with four to five mice per group. Error bars represent the mean ± SD.  
(F and G) Total number (F) and representative analysis (G) of KLRG1-expressing I-Ab ESAT-64–17–specific CD4+ T cells in the lungs of B6 or Il27ra/ mice 
over time. Data are representative of a total of four independent experiments, each with four to five mice per group. H-2Kb TB10.44–11–specific KLRG1+ 
CD8+ T cells were also assessed (right). Data are representative of two independent experiments with four mice per group. (D–F) *, P < 0.05; **, P < 0.005 
by Student’s t test. (H) Representative T-bet expression in KLRG1+ or KLRG1 antigen-specific CD4+ T cells in Mtb-infected B6 mice at day 60 after infec-
tion. (I) T-bet MFI for T-bet+, antigen-specific KLRG1+ T cells from the lungs of infected B6 and Il27ra/ was determined, and the ratio of the MFI for B6 
and Il27ra/ KLRG1+ T cells was compared with the mean of the B6. Data from two separate experiments (each with four to five mice per group) are 
combined. ***, P < 0.0001 using a one-way ANOVA followed by Dunnett’s multiple comparison test. (B, D, F, and I) The mean and SD are shown.
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that in the chronically Mtb-infected IL-27R–intact envi-
ronment, antigen-specific CD4+ T cells maintain a CD69lo, 
T-bethi, KLRG1+, IL-7Rlo phenotype.
T-bet haploinsufficiency recapitulates  
the resistance of Il27ra/ mice to Mtb
We have determined that the IL-27R–deficient mice are bet-
ter able to control bacterial burden over the long term and 
that antigen-specific CD4+ T cells in IL-27R–deficient mice 
have reduced levels of T-bet relative to those in B6 mice. 
Therefore, we wanted to determine whether the level of 
T-bet was an important parameter in the control of bacterial 
burden in Mtb infection. To do this, we determined the kinet-
ics of T-bet expression in antigen-specific T cells and found 
that although high levels of T-bet were expressed by both B6 
and Il27ra/ antigen-specific CD4+ T cells early in infection, 
T-bet expression drops over time in the Il27ra/ mice while 
remaining high in the B6; antigen-specific CD8 T cells in 
both B6 and Il27ra/ mice had high T-bet that dropped over 
time (Fig. 3 A). KLRG1 expression is dependent on T-bet ex-
pression (Joshi et al., 2007), so we compared KLRG1 in antigen-
specific CD4+ T cells in B6, Il27ra/, T-bet–haploinsufficient 
(Tbx21+/), and T-bet–deficient (Tbx21/) mice infected with 
Mtb. At day 60 after challenge, antigen-specific CD4+ T cells 
There was no significant difference between CD69 expres-
sion in the antigen-specific CD8 T cell population under the 
same conditions (Fig. 2, C and D). CD127 (IL-7R) expres-
sion has been associated with the development of long-lived 
CD8 T cells (Joshi et al., 2007), and we found that antigen-
specific CD4+ T cells from the lungs of Mtb-infected Il27ra/ 
mice express high levels of CD127 relative to the same cells 
from B6 mice (Fig. 2 E). CD127 expression in CD8 T cells was 
found to depend on KLRG1 and T-bet expression (Joshi et al., 
2007), and recently, functionally distinct subsets of antigen-
specific cells have been defined in the Mtb model based on 
expression of PD-1 and KLRG1 (Reiley et al., 2010; Sakai 
et al., 2014). We found that there was a significantly reduced 
total number and frequency of KLRG1+ antigen-specific 
CD4+ T cells in the chronically infected lungs of Mtb-infected 
Il27ra/ mice (Fig. 2, F and G). There were no significant 
differences in the frequency of KLRG1+ antigen-specific 
CD8+ T cells (Fig. 2 F). We also found that the KLRG1+ antigen-
specific CD4+ T cells in the Mtb-infected lungs were the 
highest expressers of T-bet (Fig. 2 H). Furthermore, we found 
that the ratio of T-bet signal in the Il27ra/ KLRG1+ T cells 
to the T-bet signal in the B6 KLRG1+ T cells was significantly 
below 1 for the CD4+ KLRG1+ T cells, but not for the CD8+ 
KLRG1+ T cells (Fig. 2 I). Together, these data demonstrate 
Figure 3. T-bet haploinsufficiency prevents the devel-
opment of KLRG1+ CD4+ T cells and promotes improved 
control of Mtb. (A) FACS analysis of T-bet expression by I-Ab 
ESAT-64–17–specific CD4+ (left) and H-2Kb TB10.44–11–specific 
CD8+ (right) T cells in the lungs of B6 or Il27ra/ mice over 
time. CD4 data are representative of a total of five indepen-
dent experiments with four to five mice per group. CD8 data 
are representative of two independent experiments with four 
mice per group. ***, P < 0.0001. (B) Representative T-bet 
expression in I-Ab ESAT-64–17–specific CD4+ T cells from the 
lungs of B6, Il27ra/, T-bet–haploinsufficient (Tbx21+/), 
and T-bet gene–deleted (Tbx21/) mice at day 60 after 
aerosol Mtb infection was determined by flow cytometry. 
(C) Representative FACS analysis of PD-1 and KLRG1 expres-
sion in I-Ab ESAT-64–17–specific CD4+ T cells from Mtb-infected 
B6, Il27ra/, Tbx21/+, and Tbx21/ KLRG1hi CD4+ T cells. 
(D) The frequency of I-Ab ESAT-64–17 KLRG1hi CD4+ T cells in 
the lungs of Mtb-infected B6, Il27ra/, or Tbx21+/ mice 
over time. One representative experiment of two total ex-
periments is shown, each with three to five mice per group. 
**, P < 0.005; ***, P < 0.0001 by ANOVA followed by Dun-
nett’s comparison to control (B6). (E) Tbx21+/ and B6 mice 
were infected via the aerosol route, and the number of bac-
teria in the lung was determined over time. Data are pooled 
from four independent experiments with 8–16 total mice per 
group. *, P < 0.05; **, P < 0.005. (A, D, and E) Error bars rep-
resent the mean ± SD.
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lung (Sakai et al., 2014). We therefore determined the extent 
to which IL-27R deficiency impacts the location of T cells 
within the Mtb-infected lung tissue. Using intravascular stain-
ing (Sakai et al., 2014) at day 60 of infection, we found that 
the antigen-specific T cells in the Il27ra/ mice were less 
likely to be found in the vascular compartment compared 
with the intact mice (Fig. 4, A [bottom] and B [left]). As ex-
pected (Sakai et al., 2014), the majority of KLRG1+ antigen-
specific CD4+ T cells were in the intravascular compartment 
(Fig. 4 A), whereas CXCR3-positive cells were in the paren-
chyma (Fig. 4 A). Importantly, the majority of the CD69+ and 
the PD-1+ antigen-specific CD4+ T cells were within the par-
enchyma (Fig. 4 A). Furthermore, although the mean fluor-
escence intensity (MFI) of T-bet expression was higher in the 
intravascular T cells compared with the parenchymal cells 
(Fig. 4 B, compare middle and right panels), the level of 
intrinsic T-bet expression in the antigen-specific T cells from 
the Il27ra/ mice was lower than that in the cells from B6 
mice in both populations (Fig. 4 B, middle and right). These 
data demonstrate that in the IL-27R–deficient Mtb-infected 
expressed high levels of T-bet in the B6 mice, reduced levels in 
the Il27ra/ mice, and further reduced levels in the T-bet–
haploinsufficient mice and had no expression in the T-bet gene–
deficient mice (Fig. 3 B). Furthermore, although the B6 and 
Il27ra/ mice developed an antigen-specific, KLRG1+ CD4+ 
T cell population, this population was greatly reduced or absent 
in the Tbx21+/ and Tbx21/ mice (Fig. 3, C and D). We also 
found that there was a reduced bacterial burden in the Tbx21+/ 
mice relative to the B6 mice. Importantly, reduced bacterial bur-
den and reduced KLRG1+ T cells were seen together and earlier 
in the Tbx21+/ mice than in the Il27ra/ (Fig. 3, D and E). 
These data show that an intermediate level of T-bet expres-
sion correlates with improved ability to control bacterial growth 
and that high T-bet is associated with KLRG1 expression.
Absence of IL-27R impacts location of antigen-specific 
CD4+ T cell subsets in the Mtb-infection model
Recently, it has been shown that antigen-specific T-bethi, 
KLRG1+, CD4+ T cells preferentially accumulate in the in-
travascular rather than the parenchymal compartment of the 
Figure 4. Absence of Il27ra impacts the 
localization of CD4+ T cells in the Mtb-
infected lung. (A) To characterize parenchy-
mal (Par) and intravascular lymphocytes, B6 
(top) and Il27ra/ (bottom) mice infected for 
60 d were injected with anti–CD45-FITC anti-
body 3 min before harvest, and flow analysis 
of ESAT-61–20–specific T cells was performed. 
Representative data of two independent ex-
periments, each with three to four mice, are 
shown. (B) The frequency (left) and T-bet ex-
pression levels (middle and right) of intravas-
cular antigen-specific T cells were determined. 
Data represent two experiments each with 
three to four mice per group; mean and SD 
are shown. **, P < 0.001 by Student’s t test. 
(C) B6 mice were infected for over 80 d, and 
the location of KLRG1+ (left) and PD-1+ (right) 
CD4+ T cells relative to B220+ (B cells) and 
CD11b+ (macrophages) was determined by 
immunohistochemistry. Data are pooled from 
two experiments, each containing four to five 
mice per group. **, P < 0.001; ***, P < 0.0001 
by Kruskal-Wallis test with Dunn’s multiple 
comparison test. (D, left) Frozen lung sections 
from B6 or Il27ra/ mice were stained for 
Mtb antigen (green), CD4 (red), and CD11b 
(blue) and a 20-µm perimeter (yellow lines) 
defined in ImageJ. Bar, 50 µm. (right) The 
amount of CD4 T cell signal within the perimeter 
was determined for all detectable granulomata 
in two experiments combined. ***, P < 0.001. 
(C and D) Mean and SE are shown.
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This is similar to the LCMV model wherein the level of 
inflammatory cytokine (IL-12 in this case) during priming 
defines the level of T-bet expression and KLRG1 expression 
downstream (Joshi et al., 2007).
To better define the intrinsic role of IL-27R activity on 
antigen-specific T cells in TB, we irradiated TCR/ mice 
and reconstituted them 50:50 with congenically marked B6 
and Il27ra/ BM (Fig. 5 B) to directly compare the phenotype 
of antigen-specific T cells with and without IL-27R under iden-
tical conditions. Using the illustrated gating scheme (Fig. 5 B), 
we found that although there was an equivalent frequency of 
Il27ra/ and B6 non-CD4+ lymphocytes (i.e., a ratio of 1) 
through day 120 of infection, there was a higher frequency of 
Il27ra/ CD4+ T cells (ratio above 1) skewing toward a pre-
dominance of Il27ra/ CD4+ T cells and becoming very pro-
nounced in the antigen-specific CD4+ T cell (CD4+ CD44+ 
ESAT-6+) population (Fig. 5 C). In preliminary experiments, 
the KLRG1 and T-bet expressions were not dissimilar between 
the two groups of T cells (not depicted), suggesting that the 
development of the T-bet and KLRG1 phenotype is an extrin-
sic effect of the IL-27R–deficient environment. In separate 
chimeras, we determined that the bacterial burden in the lungs 
of the mice receiving 50:50 B6/Il27ra/ BM was significantly 
reduced relative to the mice reconstituted with 100% B6 BM 
(Fig. 5 D). These data show that antigen-specific T cells that 
lack IL-27R are intrinsically more fit within the Mtb-infected 
lesion than intact T cells and that this increased fitness correlates 
with improved control of bacterial burden.
We have recently shown that a late paracrine IL-2 signal 
is required for CD4 T cells to enter into a long-lived state, 
which is associated with down-regulation of apoptotic path-
ways and permanent up-regulation of CD127 (McKinstry 
et al., 2014). In light of the high CD127 on T cells in the Mtb-
infected Il27ra/ mice and the increased fitness of Il27ra/ 
T cells, we wanted to determine whether Il27ra/ CD4+  
T cells have a differential ability to produce IL-2. Using the 
mixed BM chimera model, we found that there was a signifi-
cantly higher frequency and number of T cells capable of pro-
ducing IL-2 in response to antigen in the Il27ra/ T cells 
relative to intact T cells (Fig. 6, A and B). In contrast, although 
the number of IFN-producing T cells was increased in the 
Il27ra/ compartment, the frequency of IFN producers 
was not altered (Fig. 6 C). Furthermore, when naive B6 and 
Il27ra/ TCRTg T cells were co-transferred into congenically 
marked Mtb-infected intact mice, the frequency of IL-2–
producing Il27ra/ TCRTg T cells was increased relative to the 
B6 TCRTg T cells, whereas the frequency of IFN-producing 
TCRTg T cells remained equivalent (Fig. 6, D and E). These 
data demonstrate that the absence of IL-27R on antigen-
specific T cells in the Mtb infection model allows T cells to 
maintain an IL-2–producing phenotype.
Absence of IL-27R impacts accumulation of antigen-
specific CD4+ T cell subsets in the Mtb infection model
We wanted to examine the basis for the increased ability of 
antigen-specific T cells to accumulate in the absence of IL-27R. 
mouse, antigen-specific CD4+ T cells maintain an increased 
presence within the parenchyma relative to B6 mice.
To determine whether PD-1 and KLRG-1 are associated 
with T cell function once they are within the parenchyma, we 
determined the location of CD4+ T cells relative to B220-
positive (B cell follicle) areas or CD11b-positive (macrophage) 
areas in the lung lesions. Some KLRG1+ CD4+ T cells do 
enter the parenchyma by day 60 (Fig. 4 A), and indeed, 
a low frequency of KLRG1+ CD4+ T cells are found evenly 
distributed throughout the B cell and macrophage areas 
(Fig. 4 C). In contrast, the frequency of PD-1+ CD4+ T cells 
was higher than the KLRG1+ CD4+ T cells in both B cell and 
macrophage areas, and the PD-1+ CD4+ T cells preferentially 
associated with B cell regions relative to both the macrophage 
regions and the whole field (Fig. 4 C, right). CD4+ T cells are 
more effective when they interact directly with infected macro-
phages (Srivastava and Ernst, 2013). We therefore wanted to 
determine whether the location of CD4+ T cells relative to 
Mtb antigen within the lesional site is impacted by the ab-
sence of IL-27R activity. Using image analysis of frozen sec-
tions, we found that the amount of CD4-dependent signal 
(red) in close proximity (within 20 µm) to Mtb (green)-infected 
CD11b (blue) phagocytes was increased in the Il27ra/ mice 
(Fig. 4 D). These data demonstrate that in the Mtb-infected 
IL-27R–deficient environment, CD4+ T cell are better able 
to enter the parenchyma and interact closely with antigen- 
harboring myeloid cells.
IL-27R has intrinsic and extrinsic effects  
on CD4+ T cells in Mtb infection
Our data demonstrate that T cells lacking IL-27R are better 
than intact T cells at controlling bacterial burden in Mtb- 
infected mice (Fig. 1 C). We also show that in an IL-27R– 
deficient environment, antigen-specific CD4+ T cells have 
decreased KLRG1 and reduced T-bet (Fig. 2, F–I). To deter-
mine whether the expression of KLRG1 by T cells is a direct 
effect of IL-27R, we transferred PD-1+ CD4 T cells from the 
lungs of Mtb-infected mice into congenically marked B6 and 
Il27ra/ mice that were also Mtb infected. As expected, we 
found that the endogenous antigen-specific CD4+ T cells in 
the lungs and mediastinal LNs (MLNs) of the Il27ra/ mice 
had a reduced frequency of KLRG1+ T cells relative to B6 
T cells (Fig. 5 A, left two panels). In contrast, the transferred 
PD-1+ T cells became KLRG1+ in the lungs at the same fre-
quency regardless of the genotype of the host (Fig. 5 A, right 
two panels), whereas transferred T cells in the MLNs of 
Il27ra/ hosts exhibited a reduced frequency of KLRG1 
relative to the B6 MLNs (Fig. 5 A, right two panels). A subset 
of the B6 hosts were treated with anti–IL-27R for 10 d after 
transfer, and although this had no impact on the endogenous 
response (Fig. 5 A, left two panels), the transferred T cells ex-
hibited an unexpectedly increased frequency of KLRG1+ in 
the lung (Fig. 5 A, right two panels) and spleen (not depicted) 
but not the MLNs (Fig. 5 A, right two panels). These data 
demonstrate that the impact of IL-27R activity on T cells does 
not fit a simple model of IL-27R directly driving KLRG1. 
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we performed adoptive transfers of equal and low numbers 
of naive TCRTg ESAT-6–specific CD4+ T cells (Reiley et al., 
2008) that were either intact or lacking the Il27ra gene (2 × 104 
of each genotype) into mice infected with Mtb for either 
30 or 60 d (Fig. 7, B and C). Regardless of the time of transfer, 
Il27ra/ TCRTg ESAT-6–specific CD4+ T cells outcompeted 
B6 TCRTg ESAT-6–specific CD4+ T cells (Fig. 7, D and E), 
suggesting that the improved fitness of Il27ra/ cells is 
intrinsic and not dependent on the priming events, which 
differ for antigen and inflammation between days 30 and 60. 
Moreover, the ability of B6 TCRTg ESAT-6–specific CD4+ 
naive T cells to outcompete the Il27ra/ TCRTg ESAT-6–
specific CD4+ T cells was not likely a consequence of improved 
A previous study has demonstrated increased proliferation of 
T cells in the absence of IL-27R in the Mtb model (Hölscher 
et al., 2005), whereas our IL-2 (Fig. 6) and CD127 expression 
data (Fig. 2 E) suggest that increased survival may be important 
for the increased fitness of the IL-27R–deficient antigen- 
specific T cells (McKinstry et al., 2014). To compare prolifera-
tion in intact and Il27ra/ T cells under identical conditions 
during Mtb infection, we measured the amount of BrdU 
incorporation into B6 and Il27ra/ antigen-specific CD4+  
T cells within mixed BM chimeras over time and found de-
creased incorporation of BrdU in the Il27ra/ T cells (Fig. 7 A). 
To determine whether the impact of IL-27R deficiency on 
fitness occurred during priming of the antigen-specific T cells, 
Figure 5. CD4+ T cells that lack Il27ra are more fit than intact T cells in the Mtb lung. (A) CD4+ PD-1+ T cells were purified from congenically 
marked B6 (CD45.1) mice that had been Mtb infected for 26 d and then transferred into B6 and Il27ra/ mice that had been infected with Mtb 60–70 d 
previously. Recipient mice received isotype control or anti–IL-27R antibody for the period of the transfer (10 d). Antigen-specific endogenous (left two 
panels) and all transferred (right two panels) CD4+ T cells were examined for KLRG1 expression, and the impact of anti–IL-27R antibody treatment was 
determined in the lung and MLNs. Combined data from two experiments are shown, each with four mice per group. *, P < 0.05; **, P < 0.001; ***, P < 
0.0001 by ANOVA. (B) Competitive BM chimeras were generated by transplanting BM containing equal numbers of B6.CD45.1 and Il27ra/.CD45.2 into 
lethally irradiated TCR/ mice that were then infected with Mtb via the aerosol route. Representative FACS analysis of the lungs of chimeric mice at 
day 120 after challenge shows the gating strategy. (C) The ratio of Il27ra/ CD45.2 to B6-CD45.1 cells within each population in the lungs of chimeric 
mice after challenge was determined. Data are representative of a total of three independent experiments with four to five mice per group. (D) BM chime-
ras reconstituted with either 100% B6, Il27ra/, or mixed 50:50 B6 Il27ra/ were infected with Mtb, and the bacterial burden at day 60 after challenge 
was determined. Data are from four experiments combined. *, P < 0.05 by ANOVA. (A, C, and D) Mean and SE (A and D) or mean and SD (C) are shown.
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IL-2 production and to accumulate effectively within the Mtb-
infected lung tissue. In addition, antigen-specific T cells respond-
ing within the IL-27R–deficient environment fail to maintain 
high T-bet expression and the PD-1, CD69, KLRG1+  
T cell phenotype, which is prone to cell death and which 
populates the vascular rather than parenchymal areas of the 
lung. We suggest that the altered features of the antigen-specific 
effector T cells seen both as a result of intrinsic and extrinsic 
effects of IL-27R are responsible for their improved capac-
ity to reduce bacterial burden relative to intact mice during 
Mtb infection.
DISCUSSION
Although the protective role of effector CD4+ T cells in TB 
is recognized, the fact that we do not understand the specific 
function of these cells compromises rational vaccine design. 
We found that IL-27 is highly expressed during active TB and 
that loss of IL-27R specifically on T cells results in reduced 
Mtb burden in the mouse. In chronically Mtb-infected 
Il27ra/ mice, antigen-specific CD4+ T cells maintain CD69, 
PD-1, and CD127 expression and exhibit reduced KLRG1 
and T-bet relative to the same cells in intact mice. T-bet hap-
loinsufficient mice fail to generate KLRG1+ CD4+ T cells 
and exhibit improved protection relative to intact mice, 
thereby supporting a negative role for high T-bet expression 
in TB. In Il27ra/ mice, antigen-specific CD4+ T cells are 
better at entering the lung parenchyma and associating with 
antigen in Mtb-infected lesions than are CD4+ T cells in in-
tact mice. Critically, T cells lacking IL-27R exhibit improved 
proliferation, as both genotypes incorporated similar levels of 
BrdU after a 24-h pulse (Fig. 7 F). These data suggest that the 
increased fitness of CD4+ T cells lacking Il27ra is not a result 
of increased proliferative capacity.
Because Il27ra/ CD4+ T cells outcompete B6 CD4+  
T cells while having similar proliferation profiles, we postu-
lated that increased competitiveness was associated with dif-
ferential susceptibility of these populations to cell death. To 
test this, we measured caspase activity in CD4+ T cells from 
the lungs of Mtb-infected B6 and Il27ra/ mice with a pan-
caspase activity detector and found that CD4+ T cells from 
Il27ra/ mice expressed significantly less caspase activity 
compared with those from B6 mice at day 60 after infection 
(Fig. 7 G); cells with high caspase were also high expressers of 
Annexin (not depicted). In addition, we wanted to determine 
whether CD69 expression, which we have previously associ-
ated with increased ability to persist in mycobacterial lesions 
(Pearl et al., 2012), was associated with susceptibility of CD4+ 
T cells to cell death. Importantly, although CD69hi CD4+  
T cells displayed a small but significant increase in caspase ac-
tivity in B6 relative to Il27ra/ mice, CD69lo CD4+ T cells from 
B6 mice had a higher caspase activity than did the CD69lo 
CD4+ T cells from the Il27ra/ mice (Fig. 7 H). These data 
demonstrate that CD4+ effector T cells in intact mice are more 
likely to express markers of caspase activity than are effector 
T cells in Il27ra/ mice and are therefore more susceptible 
to cell death. Together, these data support a model wherein 
IL-27R signaling in CD4+ T cells is detrimental to bacterial 
control and reduces the capacity of the T cells to maintain 
Figure 6. CD4 T cells that lack Il27ra are 
able to maintain IL-2 production during 
chronic Mtb infection. (A) Lung cells from 
Mtb-infected BM chimeric mice generated as 
in Fig. 5 B underwent ex vivo restimulation of 
with ESAT-61–20. (B and C) The presence of 
IFN and IL-2 in B6.CD45.1 (B6, intact) and 
CD45.2.IL-27R–deficient (Il27ra/) CD4+  
T cells was determined by flow cytometry, and 
the total number and frequency of antigen-
specific T cells capable of producing IL-2 (B) 
or IFN (C) in response to ESAT-61–20 was 
determined. (D and E) Naive ESAT-61–20– 
specific TCRTg CD4 T cells with (B6–ESAT-6) 
and without (Il27ra/–ESAT-6) IL-27R  
expression were co-transferred into congeni-
cally marked Mtb-infected mice, and the lung 
cells were examined by flow cytometry 9 d 
after transfer. Panels show images of four 
concatenated samples (D), and the frequency 
of cytokine-producing TCRTg T cells was  
determined (E). Data show two independent 
experiments, each with five mice per group.  
(B, C, and E) Mean and SE are shown  
(B and C) or mean is shown (E). ***, P < 0.001 
by ANOVA.
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(Villarino et al., 2006). The increased fitness of the Il27ra/ 
antigen-specific CD4+ T cells seen here is associated with in-
creased IL-2 production, maintenance of CD69 and CD127 
expression, and decreased expression of cell death markers. 
These studies, combined with our data, suggest that during 
chronic Mtb infection autocrine IL-2 is reduced in antigen-
specific T cells by IL-27R signaling and further that the im-
proved fitness of Il27ra/ T cells is caused by the prosurvival 
rather than antiproliferative activity of IL-27. Regardless of the 
specific pathway, it is clear that IL-27R is detrimental to effec-
tor T cell accumulation in the Mtb-induced lesion and pro-
motes CD4+ effector T cell elimination during chronic TB.
Protective T cells must be able to penetrate the infected 
and inflamed lesion, and determining the factors limiting this 
penetration is critical to vaccine design (Orme et al., 2015; 
Robinson et al., 2015). Both Cxcl13 (Khader et al., 2009, 
2011) and its receptor CXCR5 (Slight et al., 2013) are re-
quired for T cells to efficiently migrate into the lung paren-
chyma and to penetrate the infected lesion. Furthermore, T cells 
expressing PD-1 and CXCR3 but not KLRG1 preferentially 
fitness relative to intact T cells under identical conditions, and 
this is associated not with increased proliferation but with 
improved capacity to produce IL-2 and reduced expression 
of markers of cell death. Together our data support a model 
wherein IL-27R acts directly on T cells to reduce their fitness 
and protective function and where the Il27ra-intact environ-
ment further compromises T cell function by altering their 
phenotype and reducing their capacity to penetrate into the 
infected lesion.
For effector T cells to protect, they must both be present 
and active at the site of infection, and this depends on their 
fitness and their ability to penetrate the inflamed lesion. We 
have previously demonstrated that expression of CD69 and 
increased transcription of IL-2, IL-2R, and IL-2R are as-
sociated with increased accumulation of CD4+ T cells in my-
cobacterial lesions (Pearl et al., 2012). Furthermore, autocrine 
production of IL-2 promotes up-regulation of CD127 (IL-7R), 
down-regulation of apoptosis pathways, and increased survival 
of CD4+ T cells (McKinstry et al., 2014), whereas IL-27R 
deficiency results in increased IL-2 in the toxoplasma model 
Figure 7. Absence of Il27ra changes the 
caspase activity of antigen-specific CD4  
T cells. (A) BM chimeric mice were infected with 
Mtb and received BrdU before harvest, and the 
percentage of BrdU-positive I-Ab ESAT-64–17–
specific CD4+ T cells from the Il27ra/ CD45.2 
or B6-CD45.1 was determined by flow. Data 
are representative of two independent experi-
ments, each with four to five mice per group.  
*, P < 0.05; ***, P < 0.001 by Student’s t test. 
(B–F) 4 × 104 naive ESAT-61–20–specific TCRTg 
CD4 T cells containing equivalent numbers of 
B6 ESAT-61–20 TCRTg and Il27ra/ ESAT-61–20 
TCRTg cells (B) were adoptively transferred into 
mice infected with Mtb for 30 or 60 d. (C) Rep-
resentative FACS analysis showing the relative 
frequency of congenically differentiated B6 
and Il27ra/ ESAT-61–20–specific TCRTg CD4+  
T cells at day 9 after transfer in the lungs.  
(D and E) Number of B6 and Il27ra/ ESAT-
61–20–specific TCRTg CD4+ T cells in the lungs 
after adoptive transfer into mice infected for 
30 (D) or 60 d (E) before transfer. Data are 
representative of nine independent experi-
ments, each with five mice per group. (F) Incor-
poration of BrdU by adoptively transferred B6 
and Il27ra/ ESAT-61–20–specific TCRTg CD4+  
T cells, after a 24-h pulse. Data are representa-
tive of two independent experiments, each 
with five mice per group. *, P < 0.05; **, P < 
0.01. (G and H) Pan-caspase activity (FLICA+) in 
lung CD4 T cells (G) or lung CD4+CD69hi and 
CD4+CD69lo T cells (H) from B6 or Il27ra/ 
mice at day 60 after infection was determined 
by flow. Data combine two experiments, each 
with four mice per group. ***, P < 0.001 by 
Student’s t test. (A and D–H) Error bars repre-
sent the mean ± SD.
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that they exhibit features of memory T cells (Moguche et al., 
2015). In a preliminary analysis, we found that the transcrip-
tional signal for Icos was significantly, if modestly, up-regulated 
in CD4+ T cells from Il27ra/ versus intact Mtb-infected 
lungs (n = 3 samples per group, fold increase of between 1.2 
and 1.5 with P = 0.02–0.007), suggesting that during chronic 
Mtb infection the IL-27R–deficient environment acts to 
drive antigen-specific CD4+ T cells away from the protec-
tive self-renewing memory phenotype to the less effective 
KLRG1 phenotype.
IL-27R modulation of T cell function during immune-
mediated responses is complex and variable and depends on 
where and when IL-27 is encountered (Hunter and Kastelein, 
2012). Although we have clear T cell–intrinsic effects of IL-27R 
in the form of protection, fitness, and IL-2 expression, it does 
not appear that IL-27R acts directly to drive high T-bet and 
KLRG1 expression. We found that the IL-27R–deficient en-
vironment reduces KLRG1 expression on transferred PD-1+ ef-
fector T cells in LNs but not lungs and that anti–IL-27R 
treatment increases KLRG1 expression in newly transferred 
PD-1+ T cells in lung but not LN. We also found that in the 
absence of IL-27R, there is loss of IL-10–producing T cells 
(unpublished data). To mimic the loss of IL-10 seen in Il27ra/ 
mice, we treated Mtb-infected B6 mice with anti–IL-10R 
(Asseman et al., 1999; Torrado et al., 2013) and found that it 
increased the frequency of KLRG1+ CD4 T cells in the LN 
but not the lung (B6 isotype lung 38 ± 6 vs. B6 anti–IL-10 
lung 41 ± 7, not significant; B6 isotype MLNs 28 ± 6 vs. B6 
anti–IL-10 MLNs 39 ± 9, P < 0.05 by Mann-Whitney, two 
experiments pooled each with four mice per group). These 
data demonstrate that the effect of IL-27R deficiency on 
KLRG1 expression is time and location dependent in Mtb 
and may relate to relative levels of pro- and antiinflammatory 
cytokines both at priming and during expression of function. 
In malaria, IL-27R acts to repress IL-12 signaling, resulting in 
an increased KLRG1+ population (Villegas-Mendez et al., 
2013), whereas in the LCMV model, IL-12 availability during 
priming drives increased T-bet and KLRG1 (Joshi et al., 2007). 
These observations combined with the potential role of IL-10 
as a regulator of IL-12 availability (Boonstra et al., 2006) and 
the fact that we see equivalent KLRG1 and T-bet expression 
in mixed chimeric mice make it clear that a simple linear model 
wherein IL-27R drives T-bet and subsequent KLRG1 expres-
sion cannot be proposed. Perhaps a better framework is that 
IL-27R signaling within the environment results in increased 
T-bet and KLRG1 expression and that this is mediated by, 
as yet, undefined factors.
IL-27 has pleiotropic effects on many cells involved in the 
immune response to pathogens. It acts to limit Th2 and Th17 
responses by limiting GATA3 and ROR()t, respectively 
(Lucas et al., 2003; Diveu et al., 2009); it induces IL-10 pro-
duction in Th1, Th2, Th17, and Tr1 cells (Hunter and Kastelein, 
2012) and T reg cells that regulate Th1-induced immuno-
pathology (Hall et al., 2012) and promotes T cell survival in a 
colitis model (Kim et al., 2013). We found increased IL-17–
producing antigen-specific T cells (unpublished data) and 
populate the lung parenchyma and are protective (Sakai et al., 
2014; Moguche et al., 2015). Although we see a few antigen-
specific KLRG1+ CD4+ T cells in the parenchyma by day 60 
after Mtb infection, the majority of lung parenchymal, antigen-
specific CD4+ T cells are CD69+, PD-1+, and CXCR3+ in 
both the B6 and Il27ra/ mice. The major difference be-
tween these mice is that, because of the reduced frequency of 
KLRG1+, CD69, and T-bethi CD4+ T cells, the majority of 
antigen-specific T cells in the Il27ra/ mice are within the 
parenchyma rather than in the vascular region. However, 
simply being in the parenchyma does not define protective 
capacity, as we know that T cells are better able to reduce 
bacterial number if they are in direct contact with infected 
phagocytes (Srivastava and Ernst, 2013). The fact that CD4+ 
T cells in Mtb-infected Il27ra/ mice are able to colocalize 
with Mtb antigen to a greater degree than are T cells in B6 
mice suggests that part of their improved protective capacity 
may result from their ability to fully penetrate into the lesion; 
this improved penetration may reflect improved migratory 
capacity. Indeed, IL-27 impacts LFA-1 and intracellular ad-
hesion molecule-1 (ICAM-1) function (Owaki et al., 2006), 
sphingosine-1-phosphate expression (Liao et al., 2007), and 
CCR5 expression (Gwyer Findlay et al., 2013), suggesting 
a variety of ways for IL-27 to regulate cell migration in 
inflamed tissue. The increased association of the PD-1+ pro-
tective T cells with B cell areas that we see here may provide 
signals that influence migratory capacity, but this needs to be 
addressed further.
The tendency for vascular antigen-specific T cells to ex-
press high levels of KLRG1 and T-bet in Mtb infection (Sakai 
et al., 2014) supports the developing consensus that KLRG1+ 
T cells are nonprotective in the TB mouse model. KLRG1+ 
T cells are good at producing IFN but are not a self-renewing 
population (Reiley et al., 2010), and Klrg1/ mice survive 
longer, with reduced bacterial burden and increased numbers 
of cytokine-producing T cells within the lung (Cyktor et al., 
2013). KLRG1+ antigen-specific T cells are less protective 
than PD-1+ T cells in transfer models (Sakai et al., 2014; 
Moguche et al., 2015), and vaccine-induced KLRG1+ antigen-
specific T cells are less able to maintain long-term control 
of bacterial burden in the lung (Lindenstrøm et al., 2013; 
Woodworth et al., 2014). Our data further support the detri-
mental impact of KLRG1 expression on T cell function and 
show that when T-bet is limiting as a result of haploinsuffi-
ciency, antigen-specific CD4+ T cells fail to develop KLRG1 
expression and the bacterial burden is significantly reduced 
relative to when T-bet is not limiting. PD-1+ antigen-specific 
T cells, while being poor cytokine producers, are a locally self-
renewing population during Mtb infection (Reiley et al., 2010). 
The expression of PD-1 is also critical to survival of Mtb 
infection in mice (Lázár-Molnár et al., 2010; Barber et al., 
2011) because of its ability to limit the pathogenic capacity of 
CD4+ T cells (Barber et al., 2011). Recently, it has been 
shown that these protective, antigen-specific PD-1+ T cells 
depend on intrinsic B cell lymphoma protein 6 (Bcl6) and in-
ducible T cell costimulator (ICOS) expression to develop and 
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TB-IRIS. Non-IRIS controls were patients who were diagnosed with 
HIV-associated TB and thereafter started ART, but did not develop TB-IRIS 
within the first 3 mo of ART. Similar to cases, they were sampled at 2 wk 
on ART and were matched with cases based on similar CD4 count, age, sex, 
and duration of anti-TB treatment. PBMCs from cases and controls were 
stimulated with H37Rv Mtb for 6 h at a multiplicity of infection of 1. RNA 
was reversed transcribed and analyzed for expression of IL-27p28 using 
primers and probes from Applied Biosystems, (QIAGEN). The fold change 
from the values obtained for unstimulated controls was determined as de-
scribed previously (Tadokera et al., 2013).
Ethical approval for a prospective, observational cohort study tracking 
HIV-TB patients receiving TB therapy before the start of ART (TB-ART2) 
was provided by the University of Cape Town’s Faculty of Health Sciences 
Research Ethics Committee (REC no. 049/2009). All participants provided 
written informed consent. Study design, patient selection criteria, and treat-
ment regimens were as described previously (Conesa-Botella et al., 2012; van 
der Plas et al., 2013). Patients were adults with serologically confirmed HIV-1 
infection and a diagnosis of pulmonary or extrapulmonary TB, ART-naive at 
the time of recruitment. Participants were followed for 12 wk to ascertain 
those that developed TB-IRIS and those that did not. Whole blood was col-
lected in sodium-heparin tubes before initiation of ART, and plasma was sepa-
rated from whole blood using Ficoll-Paque (Pharmacia Biotech). Plasma was 
stored at 80°C until use. The first 63 patients (33 TB-IRIS and 30 non-
IRIS) enrolled were selected to undergo plasma protein measurement. 10 pa-
tients (4 TB-IRIS and 6 non-IRIS) were on corticosteroid therapy at the time 
of collection, usually because of TB meningitis. Patients in both groups had 
similar clinical variables, including age, sex, CD4 count, HIV viral load, and 
site of Mtb infection. Patients who developed TB-IRIS had symptom onset at 
a median of 13 d (IQR 7–21 d) after ART initiation. The optical density of 
each plasma sample was determined using an IL-27p28 ELISA kit (eBiosci-
ence) according to the manufacturer’s instruction.
Mice. C57BL/6, B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J (TCR/), and B6.SJL- 
Ptprca Pepcb/BoyJ (CD45.1) mice were bred at the Trudeau Institute animal 
facilities from stock purchased from The Jackson Laboratory. Breeders 
of Il27ra (TCCR/WSX1)-deficient mice (Il27ra/) were provided by 
N. Ghilardi and F. deSauvage (Genentech), and the colony was established 
at Trudeau Institute. The ESAT-6 kD TCR transgenic (Tg) mice that rec-
ognize the immunodominant antigen ESAT-61–20 of Mtb, presented in 
the context of IAb, were previously described (Reiley et al., 2008) and 
have been bred to be Thy1.1 (Thy1a) positive and Rag1 negative (B6.
ESAT6Tb.Thy1a.Rag1/). Thy1.2 (Thy1b) TCRTg mice (B6.ESAT6 
Tg.Thy1b.Rag/) mice were crossed with Il27ra/ mice to generate Il27ra/-
ESAT6 Tg.Thy1b.Rag/ Tg mice. Both male and female mice between the 
ages of 6 and 12 wk old were used for experimental procedures. All proce-
dures involving live animals were performed in accordance with the Guide 
for Care and Use of Laboratory Animals of the National Institutes of Health, 
and individual procedures were approved by the Trudeau Institute Institu-
tional Animal Care and Use Committee.
Mtb aerosol infection and bacterial load determination. Mtb strain 
H37Rv was grown in Proskauer Beck medium containing 0.05% Tween-80 
to mid-log phase and frozen at 70°C. Mice were infected with a low dose 
of bacteria (75 CFUs) using a Glas-Col airborne infection system as previ-
ously described (Pearl et al., 2004). At day 1 and selected time points after 
challenge, mice were killed by CO2 asphyxiation, and the organs were asep-
tically excised and individually homogenized in saline. Organ homogenates 
were subsequently plated on nutrient 7H11 agar (BD Biosciences) for 3 wk 
at 37°C, at which point CFUs were counted.
BM chimeras and adoptive transfers. BM chimeras were generated as 
previously described (Torrado et al., 2013). In brief, donor BM from 6–8-wk-
old mice was harvested via perfusion of the femur and tibia with cold DMEM 
and subsequently resuspended in lysis buffer (155 mM NH4Cl and 10 mM 
KHCO3) to remove red blood cells (RBCs). Cells were then washed in sterile 
a reduction in IL-10 CD4+ T cells (unpublished data), but we did 
not see a change in the number of forkhead box P3 (FoxP3)–
expressing T cells (unpublished data) in the lungs of Il27ra/ 
mice infected with Mtb. In the mouse malaria model, IL-27 
regulates both antiparasite and immunopathologic responses 
(Findlay et al., 2010), as it does in Mtb (Hölscher et al., 2005), 
but this is not associated with loss of IL-10 or reduced T reg 
cells but rather caused by lost repression of IL-12–mediated 
signals and subsequently increased pathogenicity of the Th1 
T cell response (Villegas-Mendez et al., 2013). Conversely, when 
gp130 (the coreceptor with Il27ra for IL-27) is absent from 
macrophages and neutrophils in the Mtb model, the increased 
inflammation seen in Mtb-infected Il27ra/ mice (Hölscher 
et al., 2005) is lost, without any reduction in bacterial burden 
(Sodenkamp et al., 2011). This publication demonstrates that 
the inflammatory phenotype seen in the absence of IL-27R 
in the Mtb model is phagocyte dependent, whereas our data 
demonstrate that the protective phenotype is lymphocyte de-
pendent. Finally, other cytokines could be acting through 
IL-27R. Specifically, IL-27R interacts with gp130 and 
IL-6R to provide a receptor for the p28–cytokine-like fac-
tor (CLF) heterodimer, which acts on T cells and NK cells 
(Crabé et al., 2009). Also, the p28 subunit of IL-27 (Pflanz 
et al., 2004) can bind to gp130 to block the activity of IL-6, 
IL-27, and IL-11 (Stumhofer et al., 2010), and the balance 
between the cytokine subunits may be disrupted by the 
absence of the IL-27R. As the tools become available, fur-
ther studies are required to fully differentiate the role of IL-27 
on T cell function in Mtb (Hunter and Kastelein, 2012).
Together our data demonstrate that the ability of antigen-
specific CD4 T cells to penetrate and persist within the Mtb-
infected lung is negatively impacted by IL-27R, suggesting 
that vaccines that induce T cells with sustained expression of 
this receptor may not be protective. Rather, we should de-
velop vaccines that promote the development of T cells able 
to persist within the lung environment and that can colocal-
ize with infected phagocytes.
MATERIALS AND METHODS
Reanalysis of published microarray data. Normalized microarray data 
from a case-control study reporting transcriptional analysis of RNA from 
whole blood obtained from HIV+ and HIV individuals with LTB, active TB 
(TB), or OD (Kaforou et al., 2013) from South Africa and Malawi were 
downloaded from the Gene Expression Omnibus (series no. GSE37250) and 
analyzed for expression of IL-27 (p28 subunit; Illumina probe ILMN_1753758 
specific for human IL27A). Before analysis, IL-27 expression data were pro-
cessed by the transformation: log2(1 + E  min(E)), where E represents the 
initial normalized data. We used two-way analysis of variance to model IL-27 
expression as a function of two potentially interacting factors: “HIV status” 
(+ or ) and “TB” (TB disease, LTB, or OD). The South Africa and Malawi 
cohort data were analyzed separately.
Clinical studies. Ethical approval for a case-control study of transcriptional 
responses in PBMCs comparing TB-IRIS and non-IRIS individuals was 
provided by the University of Cape Town Research Ethics Committee 
(REC references 337/2004 and 173/2005). Study design, patient selection 
criteria, and treatment regimens were as described previously (Tadokera 
et al., 2011, 2013). Paradoxical TB-IRIS cases were selected randomly from 
participants who were enrolled at the time of diagnosis with paradoxical 
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Histology and immunohistochemistry. The caudal lobe of each lung was 
inflated with 10% neutral-buffered formalin and processed routinely for light 
microscopy by hematoxylin and eosin stain. For immunofluorescence staining, 
lungs were inflated gently with OCT, frozen, and sectioned. Frozen sections 
were fixed in acetone/ethanol (75:25) for 10 min, washed, and blocked with 
5% normal mouse serum (NMS) for 30 min. Primary antibodies (CD4 PE 
[BD], CD11be450 [eBioscience], rabbit anti-Mtb polyclonal [Abcam], B220 
e450 [eBioscience], KLRG1 PE [SouthernBiotech], and PD-1 PE [BioLeg-
end]) were diluted in 5% NMS and incubated with sections for 1 h. Slides 
were then washed and incubated with secondary antibody (anti–rabbit Alexa 
Fluor 594; Invitrogen) diluted in 5% NMS for 1 h and then washed. All incu-
bations were at room temperature. Images were captured using an SP5 laser-
scanning confocal microscope (Leica), and the light emissions were detected 
using the appropriate bandwidth settings and separate photomultiplier tubes. 
The data were collected as Leica image files (LIF) using LAS-AF version 
2.6.0.7266 software (Leica) and converted into TIF files using Fiji software. 
Image analysis was performed using Fiji software (ImageJ; National Institutes 
of Health). Areas of interest were drawn around either B220 (B cell)- or 
CD11b (macrophage)-positive cellular accumulations or Mtb-positive signal 
(Fig. 4 D). For Fig. 4 C, the number of CD4+ KLRG1+ (Fig. 4 C, left) or 
CD4+ PD-1+ (Fig. 4 C, right) cells was determined and the cells per unit area 
calculated. For Fig. 4 D, the Mtb-positive signal area was expanded by 20 µm 
in all directions. The total fluorescent intensity of the CD4 channel was mea-
sured for each of these areas. This was repeated for multiple areas within a slide 
and also for each animal in the experiment.
Statistical analysis. Differences between the means of experimental groups 
were analyzed using the two-tailed Student’s t test or ANOVA as appropri-
ate. Differences were considered significant where P ≤ 0.05. Inherently loga-
rithmic data from bacterial growth was transformed for statistical analysis.
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